Akiyo Claiborne

870 citations
17 papers · 382 indexed · h-index 11
Topics
Cancer therapeutics and mechanisms (10 papers)Synthesis and Biological Evaluation (7 papers)Protein Kinase Regulation and GTPase Signaling (3 papers)

In The Last Decade

Akiyo Claiborne

15 papers receiving 350 citations

Peers

Akiyo Claiborne
Comparison fields: 5 of 44
  • Organic Chemistry 264
  • Molecular Biology 206
  • Pharmacology 63
  • Oncology 38
  • Pharmaceutical Science 31
Replace Sanyi Wang with:
Sanyi Wang United States
Ahmed S. Abdelsamie Egypt
Jérémie Fournier Dit Chabert France
Keiko Ofuji Japan
Hideo Terauchi Japan
Robert R. Wilkening United States
T. MIYAMOTO Japan
Monica Abdelmalak United States
Toni Brown United States
Ken Hull United States
Akiyo Claiborne relative to Sanyi Wang United States Sanyi Wang's profile →
Citations per field
00.5×2.8×
Sanyi Wang · 1×
Citations per year

Countries citing papers authored by Akiyo Claiborne

Since Specialization
Citations

This map shows the geographic impact of Akiyo Claiborne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiyo Claiborne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiyo Claiborne more than expected).

Fields of papers citing papers by Akiyo Claiborne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiyo Claiborne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiyo Claiborne. The network helps show where Akiyo Claiborne may publish in the future.

Co-authorship network of co-authors of Akiyo Claiborne

This figure shows the co-authorship network connecting the top 25 collaborators of Akiyo Claiborne. A scholar is included among the top collaborators of Akiyo Claiborne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akiyo Claiborne. Akiyo Claiborne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 5
2 33
3 28
4 21
5 10
6
Biological activity of A-289099: an orally active tubulin-binding indolyloxazoline derivative.
36
7 3
8 33
9 9
10 0
11 4
12 12
13
Structure-activity relationships in quinolone antibacterials: design, synthesis and biological activities of novel isothiazoloquinolones.
29
14 18
15 1
16 40
17 100

About Akiyo Claiborne

Akiyo Claiborne is a scholar working on Organic Chemistry, Molecular Biology and Oncology, having authored 17 papers that have together received 382 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (10 papers), Synthesis and Biological Evaluation (7 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). The work is most often cited by research in Organic Chemistry (264 citations), Toxicology (27 citations) and Molecular Medicine (26 citations). Akiyo Claiborne has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Daniel T. W. Chu, Prabhavathi Fernandes, André G. Pernet, Carl W. Nordeen, Robert E. Maleczka, Saul H. Rosenberg, Hing L. Sham, David J. Frost, Lisa Y. Shen and D. T. W. CHU. Their work appears in journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026